Parschauer Karah Herdman 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Parschauer Karah Herdman（CIK 1677455）在 2 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-08-04）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 1,900 | $47,348 |
| 2026-06-15 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 1,899 | $46,753 |
| 2026-04-20 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 买入 | 28,895 | $0 |
| 2026-03-10 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 6,018 | $128,785 |
| 2026-03-10 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 3,508 | $79,526 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 买入 | 11,137 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 8,135 | $185,478 |
| 2026-02-19 | Evolus, Inc. (EOLS) | 董事 | 买入 | 45,559 | $0 |
| 2025-09-12 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | 卖出 | 2,450 | $76,366 |
来源：SEC Form 4 申报文件 · 截至 2026-08-04